Today's FDA Approvals & Drug Decisions - Live Updates
DELAYED 2 Min
Track FDA drug approvals and rejections as they happen. FDA decisions are among the most impactful catalysts for biotech and pharmaceutical stocks, often triggering significant price movements.
Our AI-powered feed analyzes each FDA announcement for market impact, providing real-time sentiment analysis. Gold members receive instant alerts when major FDA decisions are announced.
Pair with our momentum scanner to catch price swings. Also see: Clinical Trials News.
Stock News Live Feed
No News Found
No news articles match your current filters.
Try adjusting your filter settings or check back later.
Searching
Looking for matches for .
Frequently Asked Questions
How fast does the Stock Titan news feed publish a press release?
From the moment an official company press release is issued until Stock Titan has processed it, scored it and sent it to the live feed, on average under 50 milliseconds pass. What a reader sees depends on the account. Gold and Platinum members read the feed in real time, Silver members 30 seconds behind, free accounts one minute behind, and signed-out visitors two minutes behind. The delay is an account setting, not the speed of the feed.
What does the Stock Titan news feed cover, and what does it leave out?
The Stock Titan news feed carries official company press releases for over 10,000 US-listed stocks, with no minimum market capitalization, so a micro-cap release is carried on the same terms as a mega-cap one. It intentionally leaves out third-party articles, analyst opinions, promotional or sponsored content, social-media chatter, and rumors, even when a rumor comes from a respected outlet. A quiet feed means Stock Titan has not seen a new official statement.
What are the Rhea-AI impact and sentiment scores next to each Stock Titan headline?
Every item on Stock Titan carries two independent Rhea-AI scores on a 1 to 5 scale. Impact estimates the potential of the event to move the stock in the short term, in either direction. Sentiment measures the tone of the document's language and says nothing about how the stock will perform. On a held-out month of 2,766 market events never used in training, the impact engine matched the realized outcome exactly 57.4% of the time and was within one level 92.4% of the time. Across 78,539 scored articles in the first half of 2026, news rated Impact 5 was followed by an average absolute move of 16.0% in the primary ticker over the next trading session, and 38% of Impact 5 articles moved 5% or less.
Does Stock Titan get paid to feature or prioritize a company?
No. Stock Titan is independent, with no brokerage affiliation, no sponsored placements and no paid content. Covered companies and advertisers cannot pay to publish, promote, or prioritize feed items. Stock Titan does not execute trades, route orders, or hold customer funds, and subscription payments are processed by Lemon Squeezy, a regulated third-party billing provider.